Press Release – Pfizer
Pfizer New Zealand has developed a patient support website localised for Kiwi women with advanced breast cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz.
This new website has been designed to provide support for women with hormone-receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2–) advanced breast cancer1,2, and their carers.
Pfizer New Zealand spokesperson Elise Kelly, the Business Unit Lead for Oncology said: “We listened carefully to what patients living with advanced breast cancer and their carers told us about the support they wanted. The resulting IBRANCE NZ website will in the near future include inspiring interviews with women who want to share their experiences and help others live well. We estimate at least 1,100 New Zealand patients will benefit from IBRANCE each year.3”
Wednesday, 21 April 2021, 2:42 pm
Pfizer New Zealand has developed a patient support
website localised for Kiwi women with advanced breast
cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz.
This
new website has been designed to provide support for women
with hormone-receptor positive (HR+) and human epidermal
growth factor receptor 2 negative (HER2–) advanced breast
cancer1,2, and their carers.
Pfizer New Zealand
spokesperson Elise Kelly, the Business Unit Lead for
Oncology said: “We listened carefully to what patients
living with advanced breast cancer and their carers told us
about the support they wanted. The resulting IBRANCE NZ
website will in the near future include inspiring interviews
Press Release – Pfizer Pfizer New Zealand has developed a patient support website localised for Kiwi women with advanced breast cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz . This new website has been designed to provide support for women with hormone-receptor …
Pfizer New Zealand has developed a patient support website localised for Kiwi women with advanced breast cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz.
This new website has been designed to provide support for women with hormone-receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2–) advanced breast cancer1,2, and their carers.